comparemela.com

Onclive Tv News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dr Obeng-Gyasi on Neighborhood Opportunity and Mortality in Breast Cancer

Samilia Obeng-Gyasi, MD, MPH, discusses a retrospective study on neighborhood opportunity and all-cause mortality in patients with breast cancer.

Samilia obeng gyasiCancer centerDivision of surgical oncologyOhio state universityCancer control programSurgical oncologyThe ohio state university comprehensive cancer center james hospital amp solove research institute osucccOnclive tvBreast cancerDisparities in cancer care

Dr Jagannath on the ODAC Meeting on the Safety of Cilta-Cel in R/R Multiple Myeloma

Sundar Jagannath, MBBS, discusses takeaways from the FDA’s ODAC consensus on safety considerations with cilta-cel in relapsed/refractory multiple myeloma.

Sundar jagannathOncologic drugs advisory committeeTisch cancer instituteMultiple myelomaMount sinaiDrugs advisory committeeThe tisch cancer institute at mount sinaiOnclive tvMultiple myeloma

Dr Siefker-Radtke on Toxicities With Enfortumab Vedotin Plus Pembrolizumab in Bladder Cancer

Arlene O. Siefker-Radtke, MD, discusses toxicities associated with enfortumab vedotin plus pembrolizumab in patients with bladder cancer.

United statesArleneo siefker radtkeUniversity of texas md anderson cancer centerDepartment of genitourinary medical oncologyDivision of cancer medicineGenitourinary medical oncologyCancer medicineCancer centerStevens johnson syndromeOnclive tv

Dr Lenz on the Association Between HER2 Expression and Treatment Outcomes in mCRC

Heinz-Josef Lenz, MD, FACP, discusses the association between HER2 expression and treatment outcomes in metastatic colorectal cancer.

Heinz josef lenzClinical researchDepartment of medicineGastrointestinal oncology programColorectal centerDivision of oncologyDepartment of preventive medicineKeck school of medicinePreventive medicineKeck schoolUsc norris comprehensive cancer centerOnclive tvColorectal cancer

Dr Cobain on Endocrine Therapy–Based Treatment Strategies in HR+/HER2– Breast Cancer

Erin Frances Cobain, MD, discusses optimal endocrine therapy–based treatment strategies in later-line settings for HR-positive/HER2-negative breast cancer.

United statesErin frances cobainUniversity of michiganRogel cancer centerBreast cancer clinical research teamUniversity of michiganOnclive tvBreast cancer

vimarsana © 2020. All Rights Reserved.